Abivax
Stock NASDAQ – Stock Market Prices, News & Analysis
Abivax développe des traitements pharmaceutiques pour les maladies inflammatoires, virales et immuno-oncologiques.
$ 112.31
2.58 %
Abivax
$
112.31
2.58 %
Abivax développe des traitements pharmaceutiques pour les maladies inflammatoires, virales et immuno-oncologiques.
Price history of Abivax
Price history of Abivax
Performance & Momentum
6 Months
32.00 %
1 Year
1 380 %
3 Years
1 300 %
5 Years
1 300 %
Momentum
79
Similar stocks to Abivax
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases